Efficacy and safety of chimeric antigen receptor T cell therapy combined with zanubrutinib in the treatment of relapsed/refractory diffuse large B-cell lymphoma

Wang L, Yue C, Zhou X, Yang J, Jin B, Wang B, Huang M, Chen H, Zhou L, Tu S, Li Y
У данной статьи нет абстракта.
Chinese medical journal, 2025-02-23